Patents by Inventor Tomer Gold

Tomer Gold has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Compositions comprising dexamethasone
    Patent number: 11304961
    Abstract: A pharmaceutical composition useful for the treatment of multiple myeloma in combination with an anti-cancer drug is provided. The pharmaceutical composition includes high-dose dexamethasone or a pharmaceutically acceptable salt or solvate thereof.
    Type: Grant
    Filed: January 15, 2020
    Date of Patent: April 19, 2022
    Assignee: DEXCEL PHARMA TECHNOLOGIES LTD.
    Inventors: Caterina Kreyenborg, Elisabeth Meimberg, Corinna Tissen, Karl-Heinz Bannefeld, Tomer Gold
  • Compositions comprising proton pump inhibitors
    Patent number: 10736855
    Abstract: A composition suitable for forming a viscous suspension upon admixing with an aqueous medium, methods for its production and use thereof are provided. The composition includes a plurality of units, each unit having a core containing a proton pump inhibitor and an outer coating containing a gel-forming agent.
    Type: Grant
    Filed: February 13, 2017
    Date of Patent: August 11, 2020
    Assignee: DEXCEL PHARMA TECHNOLOGIES LTD.
    Inventors: Tomer Gold, Irit Ventura
  • COMPOSITIONS COMPRISING DEXAMETHASONE
    Publication number: 20200147106
    Abstract: A pharmaceutical composition useful for the treatment of multiple myeloma in combination with an anti-cancer drug is provided. The pharmaceutical composition includes high-dose dexamethasone or a pharmaceutically acceptable salt or solvate thereof.
    Type: Application
    Filed: January 15, 2020
    Publication date: May 14, 2020
    Applicant: Dexcel Pharma Technologies Ltd.
    Inventors: Caterina KREYENBORG, Elisabeth MEIMBERG, Corinna TISSEN, Karl-Heinz BANNEFELD, Tomer GOLD
  • Compositions comprising dexamethasone
    Patent number: 10537585
    Abstract: A pharmaceutical composition useful for the treatment of multiple myeloma in combination with an anti-cancer drug is provided. The pharmaceutical composition includes high-dose dexamethasone or a pharmaceutically acceptable salt or solvate thereof.
    Type: Grant
    Filed: December 18, 2017
    Date of Patent: January 21, 2020
    Assignee: DEXCEL PHARMA TECHNOLOGIES LTD.
    Inventors: Caterina Kreyenborg, Elisabeth Meimberg, Corinna Tissen, Karl-Heinz Bannefeld, Tomer Gold
  • COMPOSITIONS COMPRISING DEXAMETHASONE
    Publication number: 20190183907
    Abstract: A pharmaceutical composition useful for the treatment of multiple myeloma in combination with an anti-cancer drug is provided. The pharmaceutical composition includes high-dose dexamethasone or a pharmaceutically acceptable salt or solvate thereof.
    Type: Application
    Filed: December 18, 2017
    Publication date: June 20, 2019
    Applicant: Dexcel Pharma Technologies Ltd.
    Inventors: Caterina KREYENBORG, Elisabeth MEIMBERG, Corinna TISSEN, Karl-Heinz BANNEFELD, Tomer GOLD
  • PHARMACEUTICAL COMPOSITIONS COMPRISING FERRIC CITRATE AND METHODS FOR THE PRODUCTION THEREOF
    Publication number: 20190125792
    Abstract: The present invention relates to a pharmaceutical composition comprising granules which include an inert core coated with ferric citrate. The present invention also provides methods of manufacture thereof and methods of use thereof.
    Type: Application
    Filed: January 4, 2019
    Publication date: May 2, 2019
    Applicant: DEXCEL PHARMA TECHNOLOGIES LTD.
    Inventors: Tomer GOLD, Ron SCHLINGER, Yochai Yakovson
  • COMPOSITIONS COMPRISING PROTON PUMP INHIBITORS
    Publication number: 20190046457
    Abstract: A composition suitable for forming a viscous suspension upon admixing with an aqueous medium, methods for its production and use thereof are provided.
    Type: Application
    Filed: February 13, 2017
    Publication date: February 14, 2019
    Applicant: DEXCEL PHARMA TECHNOLOGIES LTD.
    Inventors: Tomer GOLD, Irit VENTURA
  • Pharmaceutical compositions comprising ferric citrate and methods for the production thereof
    Patent number: 10172882
    Abstract: The present invention relates to a pharmaceutical composition comprising granules which include an inert core coated with ferric citrate. The present invention also provides methods of manufacture thereof and methods of use thereof.
    Type: Grant
    Filed: June 18, 2015
    Date of Patent: January 8, 2019
    Assignee: DEXCEL PHARMA TECHNOLOGIES LTD.
    Inventors: Tomer Gold, Ron Schlinger, Yochai Yakovson
  • PHARMACEUTICAL COMPOSITIONS COMPRISING FERRIC CITRATE AND METHODS FOR THE PRODUCTION THEREOF
    Publication number: 20170106018
    Abstract: The present invention relates to a pharmaceutical composition comprising granules which include an inert core coated with ferric citrate. The present invention also provides methods of manufacture thereof and methods of use thereof.
    Type: Application
    Filed: June 18, 2014
    Publication date: April 20, 2017
    Applicant: DEXCEL PHARMA TECHNOLOGIES LTD.
    Inventors: Tomer GOLD, Ron SCHLINGER, Yochai Yakovson
  • BETA-1-SELECTIVE ADRENOCEPTOR BLOCKING AGENT COMPOSITIONS AND METHODS FOR THEIR PREPARATION
    Publication number: 20090068260
    Abstract: The present invention provides extended release pharmaceutical compositions of a beta blocker such as, but not limited to, metoprolol succinate as the active ingredient, optionally also comprising a diuretic such as but not limited to hydrochlorothiazide, and methods of preparing such extended release pharmaceutical compositions.
    Type: Application
    Filed: May 29, 2008
    Publication date: March 12, 2009
    Inventors: Tomer Gold, Benny Moshe, Ronny Reinberg
  • Controlled release formulation of tolterodine
    Publication number: 20080050449
    Abstract: The invention encompasses stable multiparticulate pharmaceutical compositions of tolterodine having at least one pharmaceutically acceptable excipient and at least two populations of multiparticulates each population having tolterodine or a salt thereof and the ratio of the populations is from 90:10 to 10:90 by weight, wherein after storage for 1 month at 40° C. and 75% relative humidity the difference between the dissolution profile at 4 hours is no more than about 5% when compared to the dissolution profile at the time of manufacture.
    Type: Application
    Filed: March 21, 2007
    Publication date: February 28, 2008
    Inventors: Dafna Arieli, Tomer Gold
  • Metoprolol succinate E.R. tablets and methods for their preparation
    Publication number: 20070202172
    Abstract: The present invention provides extended release pharmaceutical compositions of a beta blocker such as, but not limited to, metoprolol succinate as the active ingredient and methods of preparing such extended release pharmaceutical compositions.
    Type: Application
    Filed: May 18, 2006
    Publication date: August 30, 2007
    Inventors: Tomer Gold, Nava Shterman